Rainbow Children’s Medicare held an investor call on November 14, 2025, to discuss its Q2 and H1 FY26 financial results. Revenue increased by 6.5% to ₹445 Crore for Q2. EBITDA grew by 1% to ₹149 Crore. The company appointed Mr. Abrarali Dalal as Group CEO effective January 20, 2026. Expansion plans remain on track with new facilities and acquisitions contributing to future growth. The company maintains a positive outlook, targeting 20% growth in the next two years.
Financial Performance – Key Highlights
For the second quarter of FY26, Rainbow Children’s Medicare reported the following results:
- Revenue reached ₹445 Crore, a 6.5% increase year-over-year.
- EBITDA stood at ₹148.8 Crore, representing a 1.2% growth.
- Profit After Tax (PAT) was ₹75.6 Crore, a 4.3% decrease compared to the previous year.
For the first half of FY26:
- Revenue totaled ₹797.7 Crore, a 6.7% increase year-over-year.
- EBITDA reached ₹252.5 Crore, a 4.9% increase.
- PAT amounted to ₹129.4 Crore, a 9% growth.
Occupancy rate for the quarter was 52%.
Strategic Developments and Expansion
Rainbow Children’s Medicare has undertaken several strategic initiatives:
- Acquired Prashanthi Hospital in Warangal and Pratiksha Hospital in Guwahati, expanding its network.
- Commissioned a new hospital in Rajahmundry, East Godavari district of AP.
- Preparing for the commencement of two new spoke hospitals in Bengaluru (Electronic City and Hennur).
- Mr. Abrarali Dalal appointed as Group Chief Executive Officer, effective January 20, 2026.
Operational Performance
Outpatient volumes grew by 5.7%, and deliveries increased by 6.8% compared to the corresponding period last year. The payor mix remained balanced, with 52.8% of revenue from insurance and 47.2% from cash patients. The company’s net cash position was reported as ₹555.8 Cr as of September 30th.
Future Outlook and Guidance
Rainbow Children’s Medicare aims to achieve approximately 20% consolidated growth. The company expects to stabilize mature units at 8%-10% growth and newer units at around 25% growth.
Source: BSE